CORRECTED: FDA approves Merck vaccine to prevent shingles
Posted on: Friday, 26 May 2006, 06:51 CDT
In BOSTON story headlined "FDA approves Merck vaccine to prevent shingles," please read in second paragraph ... The vaccine is designed to prevent shingles ... instead of ... The vaccine is designed to treat shingles.
A corrected version follows.
BOSTON (Reuters) - Merck & Co. said on Friday that the U.S. Food and Drug Administration has approved its vaccine to prevent shingles, a painful disease characterized by a blistering rash.
The vaccine, Zostavax, is designed to prevent shingles in individuals over the age of 60. Shingles is caused by the reactivation of the virus that causes chickenpox.
Source: REUTERS
Related Articles
- U.S. Adults 'Needlessly Vulnerable' to Vaccine-Preventable Diseases, According to New Report
- Take Care Health Systems Offers Shingles Vaccine in US
- Take Care Health Systems Offers Shingles Vaccine Nationwide
- Adults Need Protection Against Vaccine-Preventable Diseases, Too
- Global Health Experts Unite to Combat the World's Leading Vaccine-Preventable Killer
- WellPoint to Cover Varicella Zoster Virus, or Shingles Vaccine
- FDA Approves Merck's Shingles Vaccine
- Merck Shingles Vaccine Hits FDA Snag
- FDA Review Date for Merck's Investigational Shingles Vaccine Extended to May 25, 2006
- Experimental Shingles Vaccine Proves Effective in Nationwide Study
Rating: 3.0 / 5 (21 votes)
 |
 |
Rate this article:
User Comments (0)
RSS Feeds